Immune Modulation: The peptide's effects on inflammatory pathways suggest caution for: Active autoimmune conditions Immunocompromised individuals Those taking immunomodulatory medications Populations Requiring Extra Caution Avoid or Use Extreme Caution: Active cancer or history of cancer Pregnancy or breastfeeding Children and adolescents Severe cardiovascular disease Active infections Immediately pre or post-surgery (without medical guidance) Drug Interactions Theoretical Interactions Given BPC-157's mechanisms, theoretical interactions exist with: Medications Affecting NO System: Nitrates (nitroglycerin, isosorbide) PDE5 inhibitors (sildenafil, tadalafil) Some blood pressure medications Reasoning: Combined NO system effects Anticoagulants and Antiplatelets: Warfarin Aspirin Clopidogrel Direct oral anticoagulants Reasoning: Angiogenic effects may affect bleeding Growth Hormone and Related: HGH IGF-1 Other growth-promoting compounds Reasoning: Additive growth factor effects Immunomodulators: Corticosteroids TNF-alpha inhibitors Other immunosuppressants Reasoning: Overlapping immune effects NSAIDs A Special Case Interestingly, while drug interactions are generally concerning, research suggests BPC-157 may protect against NSAID damage

Summary Keywords biomarkers, Caribbean region, diagnosis, disease susceptibility, Latin America, prognosis, prostatic neoplasms, therapeutics Citation Prada NJ, Mendivelso-Gonzlez D, Yepes S, Corredor C, Parra-Medina R, Varela R and Serrano ML (2026) Research on potential biomarkers of prostate cancer in Latin America and the Caribbean: a scoping review
The MHRA authorised a Wegovy semaglutide tablet for weight management in June 2026
Body Fat Types
Anti-nausea medications provide relief when dietary changes prove insufficient